Observational studyBMC women's health2026
Impact of female genital mutilation on sexual function and psychosocial wellbeing among Somali women: a cross-sectional study.
Observational study in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFemale Genital Mutilation (FGM) is associated with significant physical, psychological, and sexual health consequences. This study sought to examine the impact of FGM on sexual function and psychosocial well-being among women in Somalia compared to those without FGM.
methodsA total of 753 women were consecutively enrolled, including 707 with FGM and 46 without. Data collected included age, type of FGM (Types I-IV), decision-maker, and setting of the procedure. Participants completed the Female Sexual Function Index (FSFI) and the Brief Symptom Inventory-18 (BSI-18) to evaluate sexual function and psychosocial well-being.
resultsThe prevalence of FGM was 93.9%, with Type II being the most common (47.1%), followed by Type III (28.1%), Type I (18.9%), and Type IV (5.9%). Mothers were the primary decision-makers in 60.0% of cases. Sexual dysfunction was significantly more prevalent among women with FGM (64.6%) compared to those without (34.8%) (p < 0.001). The incidence of dysfunction increased with FGM severity: Type I (52.2%), Type II (60.2%), Type III (74.9%), and Type IV (90.5%) (p < 0.001). Women with FGM demonstrated significantly decreased sexual desire, arousal, lubrication, orgasm, satisfaction, and higher pain, anxiety, depression, and somatization (p < 0.001). Regression analysis revealed a strong inverse association between FGM and all domains of sexual and psychological health, with odds ratios increasing with the FGM type (Type I: OR = 2.1; Type II: OR = 2.8; Type III: OR = 5.6; Type IV: OR = 17.8).
conclusionOur findings suggest that women in FGM experience significantly greater psychosexual and psychosocial impairments compared to their non-FGM counterparts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.